The FiberNet embolic protection system (EPS), which received the FDA clearance in November 2008, is indicated for the treatment of patients receiving endovascular intervention for carotid artery disease. The product has also received CE Mark approval for use during carotid and saphenous vein graft procedures.
The FiberNet system features a three-dimensional design composed of a matrix of fibers which allows for the entrapment of smaller particles and better overall capture efficiency compared to the currently available distal protection filters. The low-profile filter is mounted on a guidewire, needing no delivery system to cross the lesion. The FiberNet EPS will treat vessels ranging from 3.5 to 7mm and its unique design ensures excellent wall apposition.
Stefan Widensohler and Andrea Venturelli, co-founders of Invatec, said: “The addition of the FiberNet device to our global carotid portfolio underscores our goal to provide the most comprehensive product offering of stents and embolic protection options to physicians and patients for the treatment of carotid stenoses.”